Go Pro
NYSE:BAX

Baxter International Q3 2026 Earnings Report

Baxter International logo
$24.06 +0.58 (+2.48%)
Closing price 09/30/2026 03:59 PM Eastern
Extended Trading
$24.00 -0.06 (-0.26%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Baxter International EPS Results

Actual EPS
N/A
Consensus EPS
$0.52
Beat/Miss
N/A
One Year Ago EPS
N/A

Baxter International Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.91 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Baxter International Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Thursday, October 29, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Baxter International Earnings Headlines

What Investors Might Be Missing On Baxter International (BAX)
Baxter Releases Inaugural Connected Hospital Report
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
Baxter International Inc. (NYSE:BAX) Stock Has Consensus Target Price of $22.45
Zacks Research Issues Optimistic Estimate for BAX Earnings
See More Baxter International Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Baxter International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Baxter International and other key companies, straight to your email.

About Baxter International

Baxter International (NYSE:BAX) is a global healthcare company that develops and markets products used in hospitals, outpatient facilities and other care settings. Its portfolio includes intravenous solutions and administration sets, infusion pumps, parenteral nutrition products, injectable medicines, surgical products and systems for medication preparation and delivery.

The company also provides products and technologies that support anesthesia, critical care, patient monitoring and other hospital workflows. Baxter’s offerings are designed to help healthcare professionals deliver therapies, manage medications and improve the efficiency and safety of patient care.

Founded in 1931, Baxter serves healthcare providers and patients in numerous countries worldwide through direct operations, distributors and other commercial partners. The company has historically been headquartered in the Chicago area and has expanded its portfolio through research, development and acquisitions. Its former kidney-care business was separated from Baxter in 2024, while Baxter continues to focus on hospital-based medical products, pharmaceuticals and care-delivery technologies.

View Baxter International Profile